Researchers at Tongji University have identified arachidonic acid (ARA) metabolism as a critical regulator of early human embryo implantation. Using a novel in vitro co-culture system of human blastoids and 3D endometrial assembloids, the team recreated the maternal-embryo interface during the implantation window and systematically mapped the metabolic dynamics of early implantation.
Because early human implantation is difficult to study directly, the metabolic events that coordinate embryo attachment, endometrial receptivity, and early trophoblast development have remained largely unclear. To address this challenge, the researchers combined their co-culture model with integrated metabolomic and transcriptomic analyses, allowing them to track dynamic metabolic and transcriptional changes across the earliest stages of implantation.
The study found that lipid metabolism is the dominant metabolic program during implantation, with long-chain polyunsaturated fatty acids (PUFAs), particularly arachidonic acid (ARA), and their downstream metabolites markedly enriched at early stages. Transcriptional analyses further showed that ARA-derived lipid mediators help shape the local inflammatory microenvironment, support endometrial decidualization, and promote trophoblast lineage progression and invasion. Single-cell RNA sequencing revealed that maternal stromal and epithelial cells are the major sources of lipid signaling, while embryonic cells rely primarily on glycolysis to meet the energy demands of rapid development.
The findings also have potential clinical relevance. In samples from patients with recurrent implantation failure (RIF), ARA metabolism was impaired and key implantation-associated markers were downregulated. Functional experiments showed that exogenous ARA could partially restore blastoid attachment and trophoblast function, suggesting that defective lipid metabolism may contribute directly to implantation failure. The team also developed a machine learning-based classifier that highlighted lipid metabolism genes as predictors of recurrent implantation failure, pointing to possible applications for clinical diagnosis and risk assessment.
Overall, the study provides a comprehensive view of lipid metabolic dynamics at the human maternal-embryo interface and establishes ARA metabolism as a central regulator of embryo implantation and endometrial receptivity. The findings advance understanding of early human pregnancy biology and may help guide future strategies for the diagnosis and treatment of implantation disorders
Science Bulletin
Experimental study